View in EDS

Ruxolitinib for ciltacabtagene autoleucel-associated refractory diarrhea.

Saved in:
Bibliographic Details
Title: Ruxolitinib for ciltacabtagene autoleucel-associated refractory diarrhea.
Authors: Blumenberg V; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Birocchi F; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Shih A; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA., Escobar G; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Mucci A; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Armstrong A; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Cirstea D; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Harris DL; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Bozym DJ; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Puliafito BR; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Newcomb R; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Dhawale TM; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Johnson PC; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., El-Jawahri A; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Jeffrey R 3rd; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Barselau AL; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Li A; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Emmanuel-Alejandro E; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Cook D; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Lindell K; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Luk SO; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Chaffee R; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Yee AJ; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Branagan A; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Raje N; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Graham CE; Comprehensive Cancer Centre, King's College London, London, United Kingdom., Hammond SP; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Transplant and Immunocompromised Host Infectious Diseases, Infectious Diseases Division, Massachusetts General Hospital, Boston, MA., Bushman FD; Department of Microbiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA., Roche AM; Department of Microbiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA., Reddy S; Department of Microbiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA., McFarland AG; Department of Microbiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA., Chen YB; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Choi BD; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Division of Neurosurgery, Massachusetts General Hospital, and Harvard Medical School, Boston, MA., Mount CW; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA., Dougan M; Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA., Nardi V; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA., Sohani AR; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA., Gallagher KME; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Maus MV; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Frigault MJ; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Leick MB; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.
Source: Blood [Blood] 2026 May 07; Vol. 147 (19), pp. 2215-2225.
Publication Type: Journal Article; Case Reports
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41592291
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Ruxolitinib for ciltacabtagene autoleucel-associated refractory diarrhea.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Blumenberg+V%22">Blumenberg V</searchLink>; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Birocchi+F%22">Birocchi F</searchLink>; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Shih+A%22">Shih A</searchLink>; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Escobar+G%22">Escobar G</searchLink>; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Mucci+A%22">Mucci A</searchLink>; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Armstrong+A%22">Armstrong A</searchLink>; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Cirstea+D%22">Cirstea D</searchLink>; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Harris+DL%22">Harris DL</searchLink>; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Bozym+DJ%22">Bozym DJ</searchLink>; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Puliafito+BR%22">Puliafito BR</searchLink>; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Newcomb+R%22">Newcomb R</searchLink>; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Dhawale+TM%22">Dhawale TM</searchLink>; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Johnson+PC%22">Johnson PC</searchLink>; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22El-Jawahri+A%22">El-Jawahri A</searchLink>; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Jeffrey+R+3rd%22">Jeffrey R 3rd</searchLink>; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Barselau+AL%22">Barselau AL</searchLink>; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Li+A%22">Li A</searchLink>; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Emmanuel-Alejandro+E%22">Emmanuel-Alejandro E</searchLink>; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Cook+D%22">Cook D</searchLink>; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Lindell+K%22">Lindell K</searchLink>; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Luk+SO%22">Luk SO</searchLink>; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Chaffee+R%22">Chaffee R</searchLink>; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Yee+AJ%22">Yee AJ</searchLink>; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Branagan+A%22">Branagan A</searchLink>; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Raje+N%22">Raje N</searchLink>; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Graham+CE%22">Graham CE</searchLink>; Comprehensive Cancer Centre, King's College London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Hammond+SP%22">Hammond SP</searchLink>; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Transplant and Immunocompromised Host Infectious Diseases, Infectious Diseases Division, Massachusetts General Hospital, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Bushman+FD%22">Bushman FD</searchLink>; Department of Microbiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.<br /><searchLink fieldCode="AU" term="%22Roche+AM%22">Roche AM</searchLink>; Department of Microbiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.<br /><searchLink fieldCode="AU" term="%22Reddy+S%22">Reddy S</searchLink>; Department of Microbiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.<br /><searchLink fieldCode="AU" term="%22McFarland+AG%22">McFarland AG</searchLink>; Department of Microbiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.<br /><searchLink fieldCode="AU" term="%22Chen+YB%22">Chen YB</searchLink>; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Choi+BD%22">Choi BD</searchLink>; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Division of Neurosurgery, Massachusetts General Hospital, and Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Mount+CW%22">Mount CW</searchLink>; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Dougan+M%22">Dougan M</searchLink>; Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Nardi+V%22">Nardi V</searchLink>; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Sohani+AR%22">Sohani AR</searchLink>; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Gallagher+KME%22">Gallagher KME</searchLink>; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Maus+MV%22">Maus MV</searchLink>; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Frigault+MJ%22">Frigault MJ</searchLink>; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Leick+MB%22">Leick MB</searchLink>; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; Hematology and Oncology Division, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227603509%22">Blood</searchLink> [Blood] 2026 May 07; Vol. 147 (19), pp. 2215-2225.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Case Reports
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7603509 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1528-0020 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200064971%22">00064971 </searchLink><i>NLM ISO Abbreviation: </i>Blood <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41592291
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1182/blood.2025032347
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2215
    Titles:
      – TitleFull: Ruxolitinib for ciltacabtagene autoleucel-associated refractory diarrhea.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Blumenberg V
      – PersonEntity:
          Name:
            NameFull: Birocchi F
      – PersonEntity:
          Name:
            NameFull: Shih A
      – PersonEntity:
          Name:
            NameFull: Escobar G
      – PersonEntity:
          Name:
            NameFull: Mucci A
      – PersonEntity:
          Name:
            NameFull: Armstrong A
      – PersonEntity:
          Name:
            NameFull: Cirstea D
      – PersonEntity:
          Name:
            NameFull: Harris DL
      – PersonEntity:
          Name:
            NameFull: Bozym DJ
      – PersonEntity:
          Name:
            NameFull: Puliafito BR
      – PersonEntity:
          Name:
            NameFull: Newcomb R
      – PersonEntity:
          Name:
            NameFull: Dhawale TM
      – PersonEntity:
          Name:
            NameFull: Johnson PC
      – PersonEntity:
          Name:
            NameFull: El-Jawahri A
      – PersonEntity:
          Name:
            NameFull: Jeffrey R 3rd
      – PersonEntity:
          Name:
            NameFull: Barselau AL
      – PersonEntity:
          Name:
            NameFull: Li A
      – PersonEntity:
          Name:
            NameFull: Emmanuel-Alejandro E
      – PersonEntity:
          Name:
            NameFull: Cook D
      – PersonEntity:
          Name:
            NameFull: Lindell K
      – PersonEntity:
          Name:
            NameFull: Luk SO
      – PersonEntity:
          Name:
            NameFull: Chaffee R
      – PersonEntity:
          Name:
            NameFull: Yee AJ
      – PersonEntity:
          Name:
            NameFull: Branagan A
      – PersonEntity:
          Name:
            NameFull: Raje N
      – PersonEntity:
          Name:
            NameFull: Graham CE
      – PersonEntity:
          Name:
            NameFull: Hammond SP
      – PersonEntity:
          Name:
            NameFull: Bushman FD
      – PersonEntity:
          Name:
            NameFull: Roche AM
      – PersonEntity:
          Name:
            NameFull: Reddy S
      – PersonEntity:
          Name:
            NameFull: McFarland AG
      – PersonEntity:
          Name:
            NameFull: Chen YB
      – PersonEntity:
          Name:
            NameFull: Choi BD
      – PersonEntity:
          Name:
            NameFull: Mount CW
      – PersonEntity:
          Name:
            NameFull: Dougan M
      – PersonEntity:
          Name:
            NameFull: Nardi V
      – PersonEntity:
          Name:
            NameFull: Sohani AR
      – PersonEntity:
          Name:
            NameFull: Gallagher KME
      – PersonEntity:
          Name:
            NameFull: Maus MV
      – PersonEntity:
          Name:
            NameFull: Frigault MJ
      – PersonEntity:
          Name:
            NameFull: Leick MB
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 07
              M: 05
              Text: 2026 May 07
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1528-0020
          Numbering:
            – Type: volume
              Value: 147
            – Type: issue
              Value: 19
          Titles:
            – TitleFull: Blood
              Type: main
ResultId 1